A
$ Value
$0
Shares
9,155
Price
$0
Filed
Jul 16
Insider
Name
Pierce James Andrew
Title
—
CIK
0001886518
Roles
Director
Transaction Details
Transaction Date
2025-07-14
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
9,155
Footnotes
Consists of Restricted Stock Units ("RSUs") that were granted upon the Reporting Person's appointment as a director of the Issuer on July 14, 2025. The RSUs will vest on June 10, 2026. RSUs are payable in shares of common stock on a one-to-one basis.
Filing Info
Pierce James Andrew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-21 | SYK | M | $0 |
| 2026-03-21 | SYK | F | $2.6M |
| 2026-03-21 | SYK | M | $0 |
| 2026-03-09 | SYK | A | $0 |
| 2026-02-04 | SYK | A | $0 |
| 2026-02-04 | SYK | A | $0 |
| 2026-02-02 | SYK | M | $1.3M |
| 2026-02-02 | SYK | F | $3.1M |
| 2026-02-02 | SYK | ▼ | $175K |
| 2026-02-02 | SYK | M | $0 |
Other Insiders at NVST (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hammes Eric D.
Chief Financial Officer
|
— | — | 2026-02-25 |
|
Keel Paul A
Chief Executive Officer
|
— | — | 2026-02-25 |
|
Nance Mark E
General Counsel
|
— | — | 2026-02-25 |
|
Reis Mischa
SVP, Strategy & Bus. Dev.
|
— | $290K | 2026-02-25 |
|
Kaabi Faez C
Chief Accounting Officer
|
— | — | 2026-02-25 |
|
Befidi Robert
President, Diagnostics
|
— | — | 2026-02-25 |
|
Nilsson Stefan
President, Nobel Biocare
|
— | — | 2026-02-25 |
|
Acurio Veronica
President, Orthodontics
|
— | — | 2026-02-25 |